1. Home
  2. Labeler Index
  3. Amgen Inc
  4. 55513-190
  5. NDC Package Code: 55513-190-01 Neulasta

NDC Package 55513-190-01 Neulasta

Pegfilgrastim Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55513-190-01
Package Description:
1 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE
Product Code:
55513-190
Proprietary Name:
Neulasta
Non-Proprietary Name:
Pegfilgrastim
Substance Name:
Pegfilgrastim
Usage Information:
Pegfilgrastim is a man-made version of a certain natural substance made in your body. It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Pegfilgrastim is given to people whose ability to make white blood cells is reduced due to chemotherapy. Some brands may also be used to increase white blood cells after exposure to large amounts of radiation. This monograph is about the following pegfilgrastim products: pegfilgrastim, pegfilgrastim-cbqv, pegfilgrastim-jmdb, and pegfilgrastim-bmez.
11-Digit NDC Billing Format:
55513019001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2549331 - pegfilgrastim 6 MG in 0.6 mL On-body Injection
  • RxCUI: 2549331 - 0.6 ML pegfilgrastim 10 MG/ML Injection
  • RxCUI: 2549331 - pegfilgrastim 10 MG/ML per 0.6 ML On-body Injection
  • RxCUI: 2549331 - pegfilgrastim 6 MG per 0.6 ML On-body Injection
  • RxCUI: 2549333 - Neulasta Onpro 6 MG in 0.6 mL Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Amgen Inc
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • PEGFILGRASTIM 6 mg/.6mL
    • Pharmacologic Class(es):
  • Granulocyte Colony-Stimulating Factor - [CS]
  • Granulocyte-Macrophage Colony-Stimulating Factor - [CS]
  • Increased Myeloid Cell Production - [PE] (Physiologic Effect)
  • Leukocyte Growth Factor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA125031
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    04-01-2002
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 55513-190-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    55513019001J2506Inj pegfilgrast ex bio 0.5mg0.5 mg0.611212

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55513-190-01?

    The NDC Packaged Code 55513-190-01 is assigned to a package of 1 syringe in 1 carton / .6 ml in 1 syringe of Neulasta, a human prescription drug labeled by Amgen Inc. The product's dosage form is injection and is administered via subcutaneous form.

    Is NDC 55513-190 included in the NDC Directory?

    Yes, Neulasta with product code 55513-190 is active and included in the NDC Directory. The product was first marketed by Amgen Inc on April 01, 2002 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 55513-190-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 55513-190-01?

    The 11-digit format is 55513019001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255513-190-015-4-255513-0190-01